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Summary
Picornaviruses encompass a large family of RNA
viruses. Some picornaviruses possess a leader (L)
protein at the N-terminus of their polyprotein. The
L proteins of encephalomyocarditis virus, a cardio-
virus, and foot-and-mouth disease virus (FMDV),
an aphthovirus, are both dispensable for replica-
tion and their major function seems to be the
suppression of antiviral host cell responses. Pre-
viously, we showed that the L protein of mengo-
virus, a strain of encephalomyocarditis virus,
inhibits antiviral responses by inhibiting type I
interferon (IFN-a/b) gene transcription. The L
protein of the FMDV is a protease (Lpro) that cleaves
cellular factors to reduce cytokine and chemokine
mRNA production and to inhibit cap-dependent
cellular host mRNA translation, thereby limiting
the production of proteins with antiviral activity.
In this study, we constructed a viable chimeric
mengovirus that expresses FMDV Lpro in place of
the authentic L protein in order to compare the
efficiency of the immune evasion mechanisms
mediated by L and Lpro respectively. We show that
in this mengovirus background the L protein is
more potent than FMDV Lpro in suppressing IFN-
a/b responses. Yet, FMDV Lpro is important to
antagonize infection-limiting responses both in
vitro and in vivo.
Introduction
The family Picornaviridae encompasses a large number
of small plus-strand RNA viruses. Due to the small size of
the genome (7–8 kb), most proteins have dual functions
serving both as facilitators of viral replication and modu-
lators of the cellular environment in order to support viral
replication. All picornaviruses have a similar genome
organization. The viral RNA contains a 5′UTR, which har-
bours replication signals as well as an internal ribosome
entry site, a single polyprotein coding region, and a 3′UTR
with a genetically encoded poly(A) tail. The polyprotein
coding region is divided into the P1, P2 and P3 regions.
The P1 region encodes the capsid proteins while the
P2 and P3 regions encode the non-structural proteins
involved in replication. Some genera of the Picornaviridae
family possess an additional non-structural protein, called
the leader (L) protein, at the N-terminal part of their
polyprotein. Most is known of the L proteins of members of
the genera Cardiovirus (e.g. Encephalomyocarditis virus
(EMCV) and Theilovirus) and Aphthovirus (e.g. foot-and-
mouth disease virus, FMDV). In contrast to the other
non-structural viral proteins, the L proteins of these
viruses are dispensable for viral RNA replication and their
main function seems to be the suppression of antiviral
responses, as such, they have been dubbed viral ‘security
proteins’(Romanova et al., 2009).
Type I interferons (IFN-a/b) are essential components
of the innate immune response against viruses. IFN-a/b
causes cells to adopt an antiviral state by inducing pro-
duction of proteins with antiviral and immunomodulatory
properties. Upon infection of cells with cardioviruses,
however, little if any IFN-a/b is produced (Zoll et al., 1996;
2002; van Pesch et al., 2001; Hato et al., 2007; Ricour
et al., 2009). Through the construction of cardioviruses
lacking L or expressing a mutant L, this protein was recog-
nized to inhibit IFN-a/b gene transcription by preventing
the activation of Interferon Regulatory Factor 3 (IRF-3), a
factor that controls gene transcription of IFN-a/b as well
as other IFN-stimulated genes. By consequence, these
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mutant viruses were found to be highly attenuated and
showed reduced pathogenicity in an in vivo mouse model
(Hato et al., 2007; Zoll et al., 1996; 2002).
The FMDV L protein is a protease (Lpro) that, although
structurally not related to cardiovirus L, also has been
implicated in restricting antiviral defence mechanisms.
The function of FMDV Lpro was studied by engineering a
FMDV lacking Lpro or containing a mutant Lpro (Piccone
et al., 1995; De Los Santos et al., 2009). These mutant
viruses replicated relatively efficiently in cells lacking a
functional IFN-a/b system but were highly attenuated in
cells with a functional IFN-a/b system and also in vivo
(Brown et al., 1996; Piccone et al., 1995; Mason et al.,
1997; Chinsangaram et al., 1999; De Los Santos et al.,
2009). Cells infected with wild-type (wt) FMDV produce
little IFN-a/b whereas cells infected with a Lpro-deleted
virus secreted higher amounts of IFN-a/b in the medium
(Chinsangaram et al., 1999; Chinsangaram et al., 2001;
De Los Santos et al., 2006). The ability of Lpro to suppress
IFN-a/b production has been linked to its function to
cleave eukaryotic initiation factor eIF4G (Devaney et al.,
1988; Kirchweger et al., 1994; Guarne et al., 1998), which
shuts off cap-dependent translation of cellular mRNAs
while leaving the cap-independent, IRES-mediated trans-
lation of the viral RNA unaffected (Jang et al., 1988). In
addition, Lpro has been shown to decrease IFN-a/b mRNA
production (~3–10-fold) by cleaving NF-kB (De Los
Santos et al., 2006; De Los Santos et al., 2007; De Los
Santos et al., 2009).
Thus, cardioviruses and aphthoviruses have evolved
different L proteins and, by consequence, different
mechanisms to suppress innate IFN-a/b responses.
Whether both viral mechanisms are equally efficient in
suppressing IFN-a/b responses is unknown. Here, we set
out to compare the activities of the L proteins of mengo-
virus and FMDV by comparing functional in vitro and in
vivo IFN-a/b responses induced by wt mengovirus, a
strain of EMCV, and a chimeric mengovirus in which L was
replaced with FMDV Lpro.
Results and discussion
Construction and characterization of chimeric virus
FMDV Lpro was cloned in mengovirus cDNA clone pM16.1
in place of mengovirus L. The first six amino acids of
mengovirus L were maintained to ensure efficient trans-
lation (Kaminski et al., 1994). The specific Lpro recognition
site (KLKG) was introduced at the C terminus to enable its
self-cleavage from the polyprotein (Fig. 1A). Transfection
of in vitro transcribed RNA into BHK-21 cells using DEAE
dextran yielded a viable chimeric virus (mengovirus-FL),
as observed previously for a chimeric Theiler’s virus
expressing Lpro of FMDV (Piccone et al., 1996). Sequence
analysis confirmed the integrity of the Lpro insert. To
confirm Lpro activity, protein synthesis and eIF4G cleavage
were compared in wt and FL virus-infected cells. To this
end, L929 cells were infected at a multiplicity of infection
(moi) of 50 TCID50 (50% tissue culture infective dose)
per cell and incubated for 30 min with methionine-free
medium containing [35S]methionine at various times post
infection (p.i.). Cells were lysed and protein synthesis
was visualized by SDS-PAGE and autoradiography. The
results (Fig. 1B) show that from 2 h p.i. little, if any, cellular
proteins were synthesized in FL virus-infected cells, while
cellular protein production is detectable until 5 h p.i. in
mengovirus-infected cells. This indicates that FMDV Lpro
rapidly inhibits cap-dependent translation. The translation
shutdown coincided with the cleavage of eIF4G, as
illustrated by the decrease in eIF4G protein levels and
the appearance of cleavage products in L929 cells by
Western blot analysis (Fig. 1B). Thus, the FL virus
expresses a functional Lpro that efficiently shuts off cap-
dependent mRNA translation.
Viral growth curves showed that the FL virus replicated
efficiently but that the end titre was always 10–20 times
lower than that of wt virus, both in BHK-21 cells and in
L929 cells (Fig. 1C). To investigate whether the lower end
titres of mengo FL were due to a reduction in the amount
of viral RNA, we determined the amount of viral RNA at
different times p.i. To this end, total RNA was isolated from
infected cells, spotted on a nitrocellulose membrane, and
hybridized to a radioactive probe, pM16.1 (full-length
mengovirus cDNA clone), labelled with [a-32P]dATP by
nick translation. The data showed that the FL virus pro-
duced equal amounts of RNA, or even more, than the wt
virus (Fig. 1D). A possible explanation for the lower end
titre of the FL virus may therefore be that there are not
enough capsid proteins produced in the later stage of
infection, when maximal viral RNA synthesis takes place
(i.e. at 6 h p.i.), to encapsidate all newly synthesized viral
RNAs.
In vitro IFN-a/b responses
Previously, we showed that mengovirus L inhibits dimer-
ization and thereby activation of IRF-3, a transcription
factor whose activity is crucial for the induction of IFN-a/b
gene transcription (Hato et al., 2007). Recent studies indi-
cate that this function of L may be coupled to its ability
to inhibit nucleocytoplasmic trafficking of proteins and
mRNAs (Delhaye et al., 2004; Lidsky et al., 2006; Porter
et al., 2006; Bardina et al., 2009; Porter and Palmenberg,
2009; Ricour et al., 2009). In contrast, the FL virus
was unable to inhibit IRF-3 dimerization (Fig. 2A), as
demonstrated by native PAGE electrophoresis, and to
completely abrogate immediate early IFN-a/b gene
transcription (Fig. 2B), as observed for the wt virus by
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RT-PCR. Unlike the wt virus (Lidsky et al., 2006), the FL
virus was unable to modify nucleocytoplasmic transport,
as shown by a normal distribution of a nucleus-targeted
GFP (GFP-NLS) (Fig. 2C). This observation is in agree-
ment with the observed inability of wt FMDV to alter
nucleocytoplasmic transport (De Los Santos et al., 2007).
This finding suggests that it is unlikely that Lpro cleaves
essential nucleoporins to disrupt nuclear pore function, a
mechanism that has been demonstrated for the 2A pro-
teases of enteroviruses and rhinoviruses (Belov et al.,
2000; Gustin and Sarnow, 2001; 2002; Belov et al., 2004;
Park et al., 2008) with which Lpro shares a number of
similarities [e.g. cleavage of eIF4G (Krausslich et al.,
1987) and NF-kB (Neznanov et al., 2005)].
Our data clearly demonstrate that FMDV Lpro has less
profound effects on IFN-a/b gene transcription than
mengovirus L. To test effects of Lpro on the production and
secretion of bioactive IFN-a/b, a bioassay was performed.
Fig. 1. Construction and characterization of FMDV leader-mengovirus chimera.
A. Schematic representation of the chimera showing the sequence for self-cleavage from the poly protein (KLK*G).
B. Left: Protein synthesis in L929 cells infected with wt and FL virus. Proteins were labelled with [35S]methionine at the indicated hours p.i.
The asterisk indicates an unknown host protein. Right: Western blot analysis showing the cleavage of eIF4G in L929 cells infected with the
FL chimera at various times (in minutes p.i.).
C. Viral growth curves of wt and FL virus on L929 and BHK-21 cell. Cells were infected at a moi of 1. At the indicated hours p.i., cells were
lysed and virus titres were determined by titration on BHK-21 cells.
D. Amount of viral RNA in L929 cells infected with wt or FL virus at the indicated times. RNA was visualized by hybridization to a radioactive
probe.
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In short, cells were infected with wt virus, FL virus, an
L-deleted virus (DL), or a mutant virus carrying a delete-
rious amino acid alteration in L (T47A), at a moi of 0.1 or
1 for 48 h. Cell culture supernatants were treated for 24 h
at pH 2, neutralized, and used for priming of fresh L929
cells. For comparison, a standard curve was made by
priming cells with serial dilutions of commercially available
mouse IFN-a/b. The primed cells were subsequently
infected with serial dilutions of wt mengovirus. The
amount of IFN-a/b produced in the cell culture superna-
tants was determined by comparing the protective effects
with those observed with the standard curve. The results
(Fig. 2D) showed that unlike the wt virus, the FL virus was
unable to completely inhibit IFN-a/b production. However,
the amount of IFN-a/b produced was about 10-fold
reduced compared with that produced in cells infected
with the mutant viruses lacking (DL) or containing an
inactive L protein (T47A). Thus, the Lpro-mediated shut-off
of cap-dependent mRNA translation reduces, but does
not completely inhibit, IFN-a/b production in vitro.
In vivo IFN-a/b responses and pathogenicity
We also tested the functional activity of Lpro in vivo. For
this, IFN-a/b gene transcription as well as pathogenicity
were analysed in mice. To monitor IFN-a/b gene transcrip-
tion, we used IFN-a/b receptor knock out (IFNAR-KO)
mice because the ability of the viruses to infect and
spread is unhindered by the antiviral activity caused by
IFN because the mice cannot respond to IFN-a/b. Four-
week-old 129/Sv IFNAR-KO mice were infected intracra-
nially with 103 TCID50 of wt or FL virus. We then measured
viral load and cytokine gene expression in the brain of the
infected mice. To this end, total RNA was extracted at
3 days p.i. and real-time RT-PCR was used to quantify
viral RNA as well as IFN-b, RANTES, and b-actin tran-
scripts. The results showed that FL virus infection resulted
in higher mRNA levels of IFN-b and RANTES than wt virus
infection, while there was no difference in replication
(Fig. 3A). The mRNA levels induced by FL virus infection
were similar as those observed in mice infected with
Fig. 2. Suppression of IFN-a/b production
in vitro.
A. IRF-3 dimerization in cells infected with
mengo wt or FL at 8 h p.i., visualized by
native PAGE.
B. IFN-a/b gene transcription in L929 cells
infected with wt or FL virus at 6 h p.i.
C. Nucleocytoplasmic traffic disorder in
infected cells. Cells were transfected with
GFP-NLS and then infected with either wt or
FL virus. The fate of GFP-NLS was monitored
at 5 h p.i.
D. Analysis of IFN-a/b production by bioassay.
L929 cells were infected with the indicated
virus at the indicated moi for 48 h. Cell culture
supernatants were treated for 24 h at pH 2,
neutralized, and used for priming of fresh
L929 cells, which were then infected with wt
virus and scored for the production of
cytopathic effect. IFN-a/b concentrations were
calculated by using a standard curve
generated with dilutions of commercially
available mouse IFN-a/b. *P < 0.05;
**P < 0.01.
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mengovirus DL and T47A mutants (Hato et al., 2007),
which were determined in a parallel experiment. Notwith-
standing the observation that Lpro has been shown to
cause a three- to five-fold reduction in transcription of
cytokine and chemokine genes in vitro (De Los Santos
et al., 2007), it is clear that the FL virus is far less potent
in inhibiting cytokine and chemokine gene transcription in
vivo than wt mengovirus.
To investigate the potential of FMDV Lpro to suppress
infection-limiting IFN-a/b responses in vivo, we com-
pared the pathogenic potential of wt, FL and DL virus in
normal mice. Six 4-week-old 129/Sv mice were infected
intraperitoneally with 104 TCID50 virus. Mice infected with
wt virus exhibited severe paralysis and 6/6 died by day
12 (Fig. 3B). Mice infected with FL virus all developed
paralysis but only 3/6 died. The other three mice were
still partially paralysed by day 18 but were recovering. In
contrast none of the mice infected with DL virus died or
showed signs of paralysis. These data indicate that,
similar as observed in vitro, the function mediated by
FMDV Lpro in vivo suppresses antiviral responses to a
certain extent, but not as efficiently as that of mengo-
virus L.
Concluding remarks
Collectively, our results show that the cardiovirus and
aphthovirus L proteins have a different mechanism and
capacity to limit IFN-a/b production both in vitro and in
vivo. The suppression of antiviral responses by FMDV
Lpro, which is mediated by its ability to decrease cytokine
and chemokine gene transcription and to suppress host
cell translation by cleaving cellular proteins, is less effec-
tive than the mengovirus L-mediated inhibition of cytokine
and chemokine gene transcription that is mediated
through the blockage of IRF-3 activation. It should be
emphasized that we cannot exclude that mengovirus L is
more potent in suppressing IFN-a/b production only in a
mengovirus background and that different results would
have been obtained with a reciprocal FMDV chimera in
Fig. 3. Suppression of IFN-a/b production and virus pathogenicity in vivo.
A. Four-week-old 129/Sv IFNAR-KO mice were infected intracranially with wt or FL virus. IFN-b and RANTES transcripts as well as
mengovirus and b-actin transcripts were quantified by real-time RT-PCR in RNA extracted from brains at 3 days p.i. Histograms show
mean  SD of cDNA copy numbers normalized to b-actin cDNA copies (¥10-4 in the case IFN-b and RANTES). **P < 0.01; ***P < 0.001.
B. Four-week-old 129/Sv mice were infected intraperitoneally with 104 TCID50 of the indicated virus and survival was charted.
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which mengovirus L was substituted for Lpro. Notwith-
standing this, the data that demonstrate that the FL
chimera is much more virulent than the DL virus in normal
mice show that the FMDV Lpro plays an important function
in virus virulence. Thus, our data clearly indicate that the
distinct, structurally unrelated picornavirus security pro-
teins are partially interchangeable at the functional level.
Experimental procedures
Cells
Baby Hamster Kidney cells (BHK-21) and L929 mouse fibroblasts
were maintained in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal bovine serum as described (Hato et al.,
2007).
Viruses
Wild-type and mutant mengoviruses (DL and T47A) have been
described previously (Hato et al., 2007). For the construction of
the chimeric mengovirus expressing FMDV Lpro, first a unique
XhoI site was introduced at position 737 with oligonucleotide
5′-GGA ATG AGC ACA AAT CTC GAG TTC CAT GGT TGT
AGC-3′ and a unique HpaI site was introduced at position 920
with oligonucleotide 5′-ATC GGA TGA GGT TGA GTT AAC TTG
TGT CTC GAA CAC-3′ by site-directed mutagenesis (restriction
sites are underlined). FMDV Lpro was amplified by PCR using
cDNA clone pMR15 [FMDV type O1K (Ryan et al., 1989)] as
template with forward primer 5′-ACA GGG AAA CTC GAG CTG
ACA CTG TAC AAC GG-3′ (XhoI site underlined) and reverse
primer 5′-GGA TTG TCC GGC GCC TTT GAG CTT GCG
TTG-3′ (EheI site underlined). The PCR product was cut with the
indicated restriction enzymes and cloned between the XhoI and
HpaI restriction sites that were introduced in mengovirus cDNA
clone pM16.1. Chimeric FL virus was produced by DEAE-
mediated transfection of BHK-21 cells with T7 RNA polymerase
generated RNA transcripts as described (Zoll et al., 2002). Virus
titres were determined using serial 10-fold dilutions of eight rep-
licates in 96 well plates containing BHK-21 monolayers. TCID50
were calculated as described (Zoll et al., 2002).
Western blot analysis
Cells were infected at moi of 50 for 30 min, grown at 37°C, and
lysed at the indicated time points. Proteins were separated on
10% SDS-PAGE gels and transferred to nitrocellulose mem-
brane. The membrane was probed with a rabbit antiserum
against amino acid residues 327–342 of eIF-4G (kindly provided
by R. Rhoads).
In vivo labelling
Cells were infected at moi 50 and incubated with methionine-free
medium containing 10 mCi ml-1 [35S]methionine at various times
p.i. After a 1 h labelling period, the cells were lysed and protein
synthesis was analysed by 12.5% SDS-PAGE gel electrophore-
sis and autoradiography as described (Zoll et al., 2002).
Viral growth analysis
Cells were infected at the indicated moi for 30 min and grown at
37°C for the indicated times. Viruses were released by three
successive cycles of freezing and thawing and titrated on
BHK-21 cells as described above.
Analysis of IRF-3 dimerization by native PAGE
Preparation of cell extracts, native PAGE, and Western blotting
with a goat polyclonal anti-IRF-3 antibody (C-20) (Santa Cruz)
were performed as described (Hato et al., 2007).
RT-PCR analysis
Total cellular RNA was harvested using GenEluteTM mammalian
total RNA Kit (Sigma) according to the manufacturer’s instruc-
tions. RNA was treated with DNase I prior to reverse transcription
and amplification by PCR. Primer sequences have been
described (Hato et al., 2007).
Interferon bioassay
Infection of cells, harvesting and acid treatment of supernatants
to inactivate virus, neutralization, priming of fresh L929 mono-
layers were all performed as described (Zoll et al., 2002). For
comparison, a standard curve was made by priming cells with
serial dilutions of commercially available mouse IFN-a/b (Sigma).
Mouse experiments and real-time RT-PCR
Infection of mice, extraction of total RNA and real-time RT-PCR
were performed as described (Paul and Michiels, 2006). Han-
dling of mice and experimental procedures were conducted in
accordance with national and institutional guidelines for animal
care and use.
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